Send Inquiry

Request To Call Back

ERLONAT ERLOTINIB 150 MG TABLETS

Get a Price/Quote

ERLONAT ERLOTINIB 150 MG TABLETS Specification

Origin of Medicine
India

Pacakaging (Quantity Per Box)
30 tablets

Salt Composition
Erlotinib 150 mg

Dosage Form
Oral

Indication
For treatment of advanced or metastatic non-small cell lung cancer and pancreatic cancer

Drug Type
Allopathic

Ingredients
Erlotinib Hydrochloride

Physical Form
Tablets

Function
Anti-cancer (tyrosine kinase inhibitor)

Recommended For
Patients with non-small cell lung cancer (NSCLC) and pancreatic cancer

Dosage
As directed by physician

Dosage Guidelines
Take exactly as prescribed by your doctor. Do not chew or crush the tablet.

Suitable For
Adults

Quantity
30 Tablets per box

Storage Instructions
Store below 30C in a dry place, away from sunlight

Strength
150 mg per tablet

ATC Code
L01EB02

Marketed By
NATCO Pharma Limited

Warning and Precautions
Use with caution in patients with hepatic or renal impairment, and in smokers.

Trade Name
ERLONAT

Colour
White to off-white

Side Effects
Common: rash, diarrhoea, fatigue, loss of appetite, breathing difficulty

Administration Route
Oral- to be taken at least 1 hour before or 2 hours after food.

Prescription/Non-Prescription
Prescription

Shelf Life
24 months from manufacturing date

ERLONAT ERLOTINIB 150 MG TABLETS Trade Information

Packaging Details
PACK OF 30 TABLETS

About ERLONAT ERLOTINIB 150 MG TABLETS

Erlonat Tablets

ERLONAT 150 MG TABLETS ERLOTINIB 150 MG

Erlonat is a medication, containingerlotinib,belonging to a class of medications termed as kinase inhibitors. Erlonat is used for treating non-small cell lung cancer. Erlonat, in combination with gemcitabine, is used for treating pancreatic cancer, which has been spread to near tissues or the other parts of the body. The medication is known for its efficacy in treatment of the cancer..

Specifications

Product Name - Erlonat 150 Mg Tablets
Content - Erlotinib Hydrochloride
Form - Tablets
Strength - 25 Mg, 100Mg, 150 Mg
Packing - Pack Of 30 Tablets
Manufactured By : Natco

Note:ErlonatIs A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug............

Precise Cancer Therapy

ERLONAT is a targeted therapy designed to disrupt the growth of cancer cells in non-small cell lung cancer and pancreatic cancer. Its tyrosine kinase inhibitor action helps slow disease progression and may improve overall treatment outcomes. Always follow your oncologists specific guidance for best results.

Easy Oral Administration

These tablets are formulated for oral use, offering patient-friendly dosing. For optimal absorption, take ERLONAT at least one hour before or two hours after meals. Never chew or crush the tablets, and only take the dose prescribed by your healthcare provider.

Safe Handling and Storage

Proper storage of ERLONAT ensures its effectiveness. Maintain the tablets below 30C, in a dry place and away from direct sunlight. Keep the medication in its original packaging and out of reach of children. Check the expiry date before use as shelf life is 24 months from the manufacturing date.

FAQs of ERLONAT ERLOTINIB 150 MG TABLETS:

Q: How should I take ERLONAT ERLOTINIB 150 MG TABLETS?

A: Take ERLONAT exactly as prescribed by your physician, swallowing each tablet whole with water at least one hour before or two hours after food. Do not chew or crush the tablets.

Q: What is ERLONAT prescribed for?

A: ERLONAT is indicated for the treatment of adults with advanced or metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer.

Q: When can I expect to see benefits from ERLONAT therapy?

A: The benefits and response to ERLONAT vary among patients. Your oncologist will monitor your progress regularly to assess treatment effectiveness and may adjust the therapy as needed.

Q: Where should I store ERLONAT ERLOTINIB tablets?

A: Store ERLONAT tablets below 30C, in a dry area, away from sunlight and moisture, and always in the original packaging.

Q: What are the common side effects of ERLONAT?

A: The most frequently reported side effects include rash, diarrhoea, fatigue, loss of appetite, and difficulty breathing. Report any severe or persistent symptoms to your physician promptly.

Q: What precautions should I take while using this medication?

A: ERLONAT should be used cautiously in patients with liver or kidney impairment and in smokers, as advised by your doctor. Always follow dosage instructions closely and attend scheduled appointments for monitoring.

Q: How does ERLONAT work as an anti-cancer medication?

A: ERLONAT acts as a tyrosine kinase inhibitor, blocking specific cellular receptors that promote cancer cell growth, thereby slowing disease progression and supporting your overall cancer treatment plan.

Tell us about your requirement